Patents by Inventor Wolfgang Ebert

Wolfgang Ebert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020141943
    Abstract: The present invention relates to iron-containing nanoparticles having a modular structure, their production, and their use for diagnostic and therapeutic purposes.
    Type: Application
    Filed: September 26, 2001
    Publication date: October 3, 2002
    Applicant: INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH
    Inventors: Mayk Kresse, Detlev Pfefferer, Ruediger Lawaczeck, Susanne Wagner, Wolfgang Ebert, Volker Elste, Wolfhard Semmler, Matthias Taupitz, Josef Gaida, Anja Herrmann, Monika Ebert, Udo Swiderski
  • Publication number: 20020052354
    Abstract: The invention relates to compounds of general formula I
    Type: Application
    Filed: January 16, 2001
    Publication date: May 2, 2002
    Applicant: Schering AG
    Inventors: Johannes Platzek, Heribert Schmitt-Willich, Ulrich Niedballa, Hanns-Joachim Weinmann, Wolfgang Ebert
  • Patent number: 6350798
    Abstract: A thermoplastic molding composition comprising aromatic polycarbonate, saccharine and a compound having at least one ester group in its structure is disclosed. The inventive composition is characterized in its improved stability and hence suitable for the preparation of stable films, compact discs and sheets.
    Type: Grant
    Filed: December 9, 1999
    Date of Patent: February 26, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Wolfgang Ebert, Ralf Hufen, Wilfried Haese
  • Patent number: 6320016
    Abstract: X-ray detectable molded articles prepared from polycarbonate resins are disclosed. The articles, preferably toys or medical equipment, are molded of polycarbonate the structure of which contains units derived from iodophenyl.
    Type: Grant
    Filed: December 9, 1999
    Date of Patent: November 20, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Michael Bödiger, Wolfgang Ebert, Heinrich Alberts, Dieter Wittmann, Thomas Eckel
  • Patent number: 6294152
    Abstract: A compound of formula (I): wherein, R1 is independently selected from methyl and ethyl and R2 is independently selected from hydrogen, alkyl, and substituted alkyl. The compound is capable of functioning as a ligand and complexing with paramagnetic Fe(III) ion for use as a second-sphere contrast enhancing agent for magnetic resonance imaging of tissue. The present invention also relates to a method of administering the second sphere contrast agent.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: September 25, 2001
    Assignees: The University of Toledo, Schering Aktiengesellschaft of Germany
    Inventors: Julian A. Davies, Wolfgang Ebert, Bernd Raduechel, Heribert Schmitt-Willich
  • Publication number: 20010020828
    Abstract: An electrical device such as a ballast for fluorescent lamps and including a housing, a terminal, and a catch element for connecting the terminal to the housing, the catch element including a catch leg for connecting the terminal to the catch element and for connecting the catch element to the housing. Accordingly, the electrical device is designed such that the individual terminal sites of the terminal have minimal positional tolerance so that the terminal can be wired with an automatic installation machine without the danger of misinsertions.
    Type: Application
    Filed: March 7, 2001
    Publication date: September 13, 2001
    Inventors: Jurgen Feye-Hohmann, Wolfgang Ebert, Gunther Lohmann, Axel Becker
  • Patent number: 6269004
    Abstract: An electric module which includes a printed circuit board and at least one electrical subassembly arranged thereon is disposed within a metallic housing and is grounded to the metallic housing by way of a wire bridge which extends transversely across a cutout disposed in the printed circuit board. The metallic housing is integrally connected to a contact tongue which extends through the cutout and the printed circuit board before engaging the wire bridge. The wire bridge connects one side of the printed circuit board to a ground conductor track disposed on the opposing side of the printed circuit board. Preferably, the contact tongue includes two closely spaced contact elements that are spaced apart for frictionally receiving the wire bridge therebetween.
    Type: Grant
    Filed: June 8, 1999
    Date of Patent: July 31, 2001
    Assignee: Siemens Aktiengesellschaft
    Inventor: Wolfgang Ebert
  • Patent number: 6248306
    Abstract: Cascade polymer complexes containing a) complexing ligands of general formula I A—{X—[Y—(Z—( W—Kw)z)y]x}a  (I)  in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand for a direct bond or a cascade reproduction unit of reproduction multiplicity x or y, Z and W, independently of one another, stand for a cascade reproduction unit of reproduction multiplicity z or w, K stands for the radical of a complexing agent, a stands for numbers 2 to 12, x, y, z and w, independently of one another, stand for numbers 1 to 4, provided that at least two reproduction units are different and that 16≦a·x·y·z·w≦64 holds true for the product of the multiplicities, b) at least 16 ions of an element of atomic numbers 20 to 29, 39, 42, 44 or 57-83 and c) optionally cations of inorganic and/or organic bases, amino acids or amino acid amides are valuab
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 19, 2001
    Assignee: Schering Aktiengesellschaft
    Inventors: Heribert Schmitt-Willich, Johannes Platzek, Ulrich Niedballa, Bernd Raduchel, Andreas Muhler, Thomas Frenzel, Wolfgang Ebert
  • Patent number: 6197854
    Abstract: A thermoplastic polycarbonate molding composition having improved resistance to gamma radiation-induced yellowing is disclosed. Particularly suitable for the manufacture of devices targeted for medical applications, the composition contains additive amounts of a first stabilizing compound conforming structurally to wherein in the embodiment where n is 1, R1 is an unsubstituted or substituted carbocyclic or heterocyclic aromatic ring system, and where in the embodiment where n is 2, R1 is unsubstituted or C1-4-alkyl or hydroxy substituted phenylene or naphthylene, and R2, R3, R4 and R5 independently of one another are hydrogen, C1-25-alkyl groups or phenyl. and a saccharine compound.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: March 6, 2001
    Assignees: Bayer Corporation, Bayer Aktiengesellschaft
    Inventors: Sivaram Krishnan, Wolfgang Ebert
  • Patent number: 6160156
    Abstract: The invention relates to a process for the preparation of aromatic oligocarbonates from dihydroxy compounds, CO and O.sub.2 in the presence of a platinum metal catalyst, a cocatalyst, a quaternary salt and a base, which is carried out in an inert organic solvent which, under the reaction conditions, forms an azeotrope with water, and this azeotrope is removed from the reaction mixture.
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: December 12, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Claus-Peter Reisinger, Wolfgang Ebert
  • Patent number: 6146615
    Abstract: A compound of formula (I): ##STR1## wherein, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are selected independently from hydrogen, alkyl, and alkyl substituted with one or more --O-- atoms, or where R.sup.1, R.sup.2 and R.sup.3, R.sup.4 are ring residues. The compound is capable of functioning as a ligand and complexing with paramagnetic Fe(III) ion for use as a second-sphere contrast enhancing agent for magnetic resonance imaging of tissue, and a method of administering the second sphere contrast agent.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: November 14, 2000
    Assignees: The University of Toledo, Schering Aktiengesellschaft
    Inventors: Julian A. Davies, Wolfgang Ebert, Bernd Raduechel
  • Patent number: 6136841
    Abstract: 3-,8-substituted deuteroporphyrin derivatives with various substituents in the 13- and 17-positions of the porphyrin skeleton are suitable as pharmaceutical agents for use in photodynamic therapy (PDT) and for MRI therapy monitoring.
    Type: Grant
    Filed: June 2, 1999
    Date of Patent: October 24, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Johannes Platzek, Ulrich Niedballa, Bernd Raduechel, Wolfgang Ebert, Hanns-Joachim Weinmann, Thomas Frenzel
  • Patent number: 6114321
    Abstract: The invention relates to new porphyrin complex compounds, pharmaceutical agents that contain the latter, and the use of porphyrin complexes for the production of agents for photodynamic therapy and MRI diagnosis.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: September 5, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Johannes Platzek, Ulrich Niedballa, Bernd Raduechel, Hanns-Joachim Weinmann, Thomas Frenzel, Wolfgang Ebert
  • Patent number: 6083479
    Abstract: The invention relates to new compounds that are suitable as contrast media especially for infarction and necrosis imaging, process for their production and pharmaceutical agents that contain these compounds.
    Type: Grant
    Filed: September 22, 1998
    Date of Patent: July 4, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Johannes Platzek, Ulrich Niedballa, Bernd Raduechel, Wolfgang Ebert, Hanns Joachim Weinmann
  • Patent number: 6066700
    Abstract: A process for the production of polysiloxane/polycarbonate block cocondensation products is disclosed. The process comprises reacting in the melt at temperatures of 250 to 320.degree. C. and pressures of 0.01 to 100 mbar (a) a hydroxyaryloxy-terminated dimethylsiloxane with (b) an oligocarbonate. The oligocarbonate is characterized in that its weight average molecular weight is 3000 to 24000 and the molar ratio of its OH end groups to aryl end groups is 10:90 to 70:30. The weight ratio of said (a) to said (b) in the inventive process is between 1:99 and 40:60. Also disclosed are the products prepared by the process.
    Type: Grant
    Filed: July 9, 1999
    Date of Patent: May 23, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Annett Konig, Wolfgang Ebert, Walter Kohler
  • Patent number: 6057419
    Abstract: Cascade polymer complexes that contain a) complexing ligands of general formula (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand for a direct bond or a cascade reproduction unit of reproduction multiplicity x or y, z and W, independently of one another, stand for a cascade reproduction unit of reproduction multiplicity z or w, K stands for the radical of a complexing agent, a stands for numbers 2 to 12, x, y, z and w, independently of one another, stand for numbers 1 to 4, provided that at least two reproduction units are different, and that 16.ltoreq.a.multidot.x.multidot.y.multidot.z.multidot.w.ltoreq.
    Type: Grant
    Filed: June 4, 1998
    Date of Patent: May 2, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Heribert Schmitt-Willich, Johannes Platzek, Bernd Raduchel, Hanns-Joachim Weinmann, Wolfgang Ebert, Bernd Misselwitz, Andreas Muhler, Thomas Frenzel
  • Patent number: 6048515
    Abstract: Modular iron-containing nanoparticles are disclosed, as well as their production and use in diagnosis and therapy. The nanoparticles are characterised in that they have an iron-containing core, a primary coat (synthetic polymer) and a secondary coat (target polymer), and optional auxiliary pharmaceutical substances, pharmaceuticals and/or adsorption mediators.
    Type: Grant
    Filed: June 25, 1997
    Date of Patent: April 11, 2000
    Assignees: Institut fur Diagnostikforschung GmbH, Der Freien Universitat Berline
    Inventors: Mayk Kresse, Detlev Pfefferer, Rudiger Lawaczek, Susanne Wagner, Wolfgang Ebert, Volker Elste, Wolfhard Semmler, Matthias Taupitz, Josef Gaida, Anja Herrmann, Monika Jukl, Udo Swiderski
  • Patent number: 6046301
    Abstract: A transparent thermoplastic molding composition having good release properties is disclosed. The composition which contains no magnetic elements contains a polycarbonate resin and 0.01 to 0.3 percent by weight of a mold release agent. The agent is the product of a reaction of a compound represented by formula (I) ##STR1## where R.sub.1 denotes a C.sub.1-30 -alkyl group, with at least one member selected from the group consisting of ##STR2## where R.sub.2 and R.sub.3 independently denote C.sub.1-30 - alkyl or an aryl group, and ##STR3## where n is 1-7.
    Type: Grant
    Filed: April 12, 1999
    Date of Patent: April 4, 2000
    Assignees: Bayer Corporation, Bayer Aktiengesellschaft
    Inventors: Daniel H. Bolton, Sivaram Krishnan, Jon M. Newcome, Jeffrey M. Tennant, David M. Derikart, Ramesh M. Pisipati, Wolfgang Ebert
  • Patent number: 6019959
    Abstract: Oligomeric compounds that contain perfluoroalkyl of general formula IA--R.sup.F (I)in whichA is a molecule portion that contains 2-6 metal complexes that are connected directly or via a linker to a nitrogen atom of an annular skeleton chain, andR.sup.F is a perfluorinated, straight-chain or branched carbon chain with formula --C.sub.n F.sub.2n E, in which E represents a terminal fluorine, chlorine, bromine, iodine, or hydrogen atom and n stands for numbers 4-30,are valuable compounds for diagnosis, especially as in-vivo contrast media.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: February 1, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Johannes Platzek, Ulrich Niedballa, Bernd Raduchel, Wolfgang Schlecker, Hanns-Joachim Weinmann, Thomas Frenzel, Bernd Misselwitz, Wolfgang Ebert
  • Patent number: 5936007
    Abstract: The present invention provides polycarbonate moulding compositions containing polycarbonates, stabilisers of the general formula (I)R.sub.1 --X--(CHR.sub.4).sub.n --Y--R.sub.2and optionally polypropylene glycols.The present invention also provides use of these moulding compositions for preparing items for medical applications.
    Type: Grant
    Filed: July 14, 1998
    Date of Patent: August 10, 1999
    Assignee: Bayer AG
    Inventors: Wolfgang Ebert, Ralf Hufen, Heidemarie Pantke, Klaus Berg